Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 10,000 shares at $15.40 ($153K) on 2006-02-01, disclosed to the SEC on 2006-02-03.
Scheduled sale ($153k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.24 | 1,246 | $19K | 12.4% |
| 2 | $15.25 | 2,071 | $32K | 20.6% |
| 3 | $15.30 | 2,968 | $45K | 29.6% |
| 4 | $15.40 | 1,465 | $23K | 14.7% |
| 5 | $15.43 | 715 | $11K | 7.2% |
| 6 | $15.49 | 1,535 |
| $24K |
| 15.5% |
| Total | $15.34 avg | 10,000 | $153K | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |